FBRX SCHEDULE 13G/A: SEC filing

An institutional holder

Filed with the SEC on Nov 4, 2026 · accession 0000929638-26-004231

FBRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 4, 2026. An institutional holder filed an amended Schedule 13G for Forte Biosciences, Inc. (FBRX), indicating a change in its passive ownership position.

Summary of the filing

An institutional holder filed an amended Schedule 13G for Forte Biosciences, Inc. (FBRX), indicating a change in its passive ownership position. The filing text provided does not disclose the specific holder, ownership percentage, or share count.

For details, click here →

Key details

IssuerForte Biosciences, Inc.

✦ Ask GOAX AI about this filing — what it means for FBRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for FBRX?

Click here

Frequently asked questions

What did FBRX file with the SEC on Nov 4, 2026?

FBRX filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Forte Biosciences, Inc. (FBRX), indicating a change in its passive ownership position. The filing text provided does not disclose the specific holder, ownership percentage, or share count.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other FBRX SEC filings

Get alerts when FBRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

FBRX overview FBRX analysis FBRX news Latest SEC filings